Target intelligence / Profile preview

Damaged mucosal proteins at ulcer sites

Molecular classification
Other
01

Overview

Damaged mucosal proteins at ulcer sites is a non-canonical, descriptive phrase referring to the various proteins that are altered, denatured, exposed, or upregulated in the gastrointestinal mucosa during ulcer formation, such as peptic ulcers. These proteins include structural molecules (e.g., occludin), stress proteins (e.g., heat shock proteins), growth factors (Epidermal Growth Factor, Trefoil Factors), enzymes (nitric oxide synthase), and others involved in the mucosal injury response. Their upregulation and activity are part of the body's endogenous efforts to heal mucosal lesions by promoting restitution of the epithelial layer, modulating inflammation, and driving tissue repair. However, this label does not correspond to a single pharmacological or molecular target, and therapies instead aim to reduce damage, enhance healing, or target underlying causes such as Helicobacter pylori infection or NSAID toxicity. In summary, this "target" is not a recognized molecular entity but a collection of proteins, molecular pathways, and tissue alterations seen in the context of mucosal injury and ulceration, with many potential biomarkers but no direct drugs or mechanisms of action associated with the entity itself.

Other names
Damaged ulcer-site mucosal proteinsExposed mucosal proteins in ulcerMucosal injury proteinsDenuded mucosal area proteins
02

Biological functions

Cytoprotection (repair response)Cell migration (epithelial restitution)Inflammatory responseCell death/apoptosisStress adaptations (e.g., heat shock protein activity)
03

Disease associations

Ulcer formation (peptic ulcer)InflammationInfection (e.g., Helicobacter pylori-induced injury)
04

Biomarkers

Heat shock proteins (HSP70, HSP90, HSP27—upregulated at damaged mucosa)Trefoil Factors (TFF1/pS2, TFF2/SP, TFF3/ITF)Epidermal growth factor and its receptor (EGF, EGFR)Nitric oxide synthase (NOS)

Beyond the preview

Go deeper on Damaged mucosal proteins at ulcer sites.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Damaged mucosal proteins at ulcer sites.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call